Zeeshan Saeed

Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation.

Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation.

Celly Nutrition Corp. is an early-stage research and development company, which engages in the business of developing and manufacturing consumer products in the dietary supplement industry. The firm is also involved in certain intellectual property assets to create recreational and consumer prototype products that are expected to alleviate inebriation due to excessive alcohol consumption. The company was founded on August 13, 2021 and is headquartered in Toronto, Canada.

Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation.

Celly Nutrition Corp. is an early-stage research and development company, which engages in the business of developing and manufacturing consumer products in the dietary supplement industry. The firm is also involved in certain intellectual property assets to create recreational and consumer prototype products that are expected to alleviate inebriation due to excessive alcohol consumption. The company was founded on August 13, 2021 and is headquartered in Toronto, Canada.